Search
"A prioritization study with infection preventionists using the SHEA CLABSI prevention framework identified priorities for IVCare intervention testing as: vascular access teams, education/competency for CVAD insertion/post-insertion care, sutureless securement, connector type and decontamination method” Rickard et al (2025).
central venous access devices

Abstract:

Healthcare-associated bloodstream infections are serious complications of central venous access devices (CVADs). Numerous preventative interventions exist, but without high-level evidence. The IVCare adaptive platform trial will provide multiple answers for infection prevention. A prioritization study with infection preventionists using the SHEA CLABSI prevention framework identified priorities for IVCare intervention testing as: vascular access teams, education/competency for CVAD insertion/post-insertion care, sutureless securement, connector type and decontamination method.

Reference:

Rickard CM, Stewardson AJ, Havers SM, Buetti N, Polkinghorne KR, MacPhail A, McQuilten Z, Lazarus B, Charles KR, Schults JA; IVCare Trial Study Group. Interventions to prevent bloodstream infections associated with central venous access devices: priorities for an adaptive platform trial. Am J Infect Control. 2025 Jun 6:S0196-6553(25)00411-0. doi: 10.1016/j.ajic.2025.06.003. Epub ahead of print. PMID: 40484028.

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey